Clinical Trial: Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical Resection

U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06934070) titled 'Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical Resection' on April 03.

Brief Summary: Evaluate the predictive value of the CALLY index and ALBI grading for the prognosis of patients with hepatocellular carcinoma (HCC) after radical resection, so as to provide a reference for clinical treatment.

Study Start Date: April 03

Study Type: OBSERVATIONAL

Condition: Hepatocellular Carcinoma (HCC) Hepatocellular Carcinoma (HCC) Prognosis

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Qiang Xu

Information provided by (Responsible Party): Qiang Xu, Jiangxi Provincia...